UNSPSC 41141925: Bilirubin (total or direct) test system

In this classification, Bilirubin (total or direct) test system connotes a device used to measure Bilirubin (total or direct) levels. US FDA regulates Bilirubin (total or direct) test system under 21 CFR 862.1110 and under FDA product code CIG.

UNSPSC 41141925 Bilirubin (total or direct) test system is a Commodity code that state and local governments are using to procure laboratory reagents, test kits, and certified reference materials for forensic and clinical substance analysis, though the recent solicitations show significant scope divergence from the code's nominal bilirubin-testing title. The issuing bodies include state forensic laboratories (Texas Department of Public Safety Crime Lab Division, Florida Department of Law Enforcement pass-through for Pinellas County), state health agencies (Texas Department of State Health Services), and state correctional systems (Texas Department of Criminal Justice). Scope includes direct ELISA testing kits for controlled-substance screening (cannabinoids, opiates, PCP, amphetamines, barbiturates, cocaine, benzodiazepines, and other drugs), certified drug reference standards with ISO/IEC 17025:2017 accreditation, DNA screening kits for PCR applications, and emergency laboratory equipment procurement. The code appears to serve as a catch-all Commodity tier classification for laboratory consumables and reagent systems across forensic and clinical functions rather than a precise bilirubin-testing marker.

Recent activity concentrates in Texas and Florida. The Texas Department of Public Safety issued IFB 405-26R0008445A on July 9, 2026, due July 23, 2026, for 12 line items of Direct ELISA reagent kits for drug substance analysis with deliveries to the Crime Lab Division in Austin. Pinellas County, Florida, issued ITQ 26-0305-ITQ on April 23, 2026, due the same day, for 131 line items of certified drug reference standards (ISO 17034:2016 compliant, ≥97% purity) funded through the Paul Coverdell Forensic Sciences Improvement Act Program at $49,034.00 for equipment and supplies. The Texas Health and Human Services Commission issued IFB HHS0016902v2 on February 10, 2026, due January 29, 2026, for QIAxcel and QIAamp DNA screening kits with historical procurement value of $25,050–$30,000 annually. A notice of intent to award from the Illinois Department of Financial and Professional Regulation (May 4, 2026, due May 20, 2026) established a joint purchase master contract for mosquito-testing equipment (RAMP System test kits) to serve multiple state and local jurisdictions, though this procurement lies outside the bilirubin-testing and drug-standards scope that dominates the recent activity under the code.